Clinical Trial

Evaluation of Different Perimetric Grids to Detect Central Visual Field Defect in Glaucoma Patients with Reduce Ganglion Cell Layer Thickness Measured by Spectral Domain OCT.

Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the study is to evaluate the agreement between three different grids in detecting central visual field defect in early glaucoma patients with reduced ganglion cell layer thickness.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-01-18.
Trial Details
NCT Number NCT06227611
Lead Sponsor Fondazione G.B. Bietti, IRCCS
Conditions Glaucoma
Enrollment 16 participants
Start Date 2021-05-04
Primary Completion 2022-05-04 (estimated)
Study Completion 2025-05-04 (estimated)
Updated on ClinicalTrials.gov 2025-02-27